PT2152305E - Proteção imediata contra agentes patogénicos através do vírus mva - Google Patents

Proteção imediata contra agentes patogénicos através do vírus mva Download PDF

Info

Publication number
PT2152305E
PT2152305E PT87491452T PT08749145T PT2152305E PT 2152305 E PT2152305 E PT 2152305E PT 87491452 T PT87491452 T PT 87491452T PT 08749145 T PT08749145 T PT 08749145T PT 2152305 E PT2152305 E PT 2152305E
Authority
PT
Portugal
Prior art keywords
protection against
against pathogens
immediate protection
pathogens via
mva
Prior art date
Application number
PT87491452T
Other languages
English (en)
Inventor
Hubertus Hochrein
Meredith O'keeffe
Original Assignee
Bavarian Nordic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bavarian Nordic As filed Critical Bavarian Nordic As
Publication of PT2152305E publication Critical patent/PT2152305E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT87491452T 2007-04-27 2008-04-25 Proteção imediata contra agentes patogénicos através do vírus mva PT2152305E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92404807P 2007-04-27 2007-04-27
US93592007P 2007-09-06 2007-09-06
US12/026,612 US8268327B2 (en) 2007-04-27 2008-02-06 Immediate protection against pathogens via MVA

Publications (1)

Publication Number Publication Date
PT2152305E true PT2152305E (pt) 2016-01-14

Family

ID=39720662

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87491452T PT2152305E (pt) 2007-04-27 2008-04-25 Proteção imediata contra agentes patogénicos através do vírus mva

Country Status (15)

Country Link
US (3) US8268327B2 (pt)
EP (1) EP2152305B1 (pt)
JP (3) JP5702137B2 (pt)
AU (1) AU2008243344B2 (pt)
CA (1) CA2676809C (pt)
CY (1) CY1117301T1 (pt)
DK (1) DK2152305T3 (pt)
ES (1) ES2556175T3 (pt)
HU (1) HUE025635T2 (pt)
IL (1) IL200073A (pt)
MY (1) MY162218A (pt)
NZ (1) NZ578662A (pt)
PT (1) PT2152305E (pt)
SI (1) SI2152305T1 (pt)
WO (1) WO2008131927A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230198B1 (hu) * 2000-11-23 2015-10-28 Bavarian Nordic A/S Módosított Vacciniavírus Ankara-variáns
CN101128217B (zh) 2005-02-23 2012-04-25 巴法里安诺迪克有限公司 改良的痘病毒快速诱导抗痘病毒或其它传染物的免疫力的用途
US8268327B2 (en) 2007-04-27 2012-09-18 Bavarian Nordic A/S Immediate protection against pathogens via MVA
JP2013507107A (ja) * 2009-10-08 2013-03-04 バヴァリアン・ノルディック・アクティーゼルスカブ Ｈｉｖに対するヒトにおける広範なｔ細胞応答の生成
WO2011066454A1 (en) * 2009-11-24 2011-06-03 Inviragen, Inc. Compositions, methods and uses for expression of enterobacterium-associated peptides
GR1008855B (el) * 2014-12-16 2016-09-27 Ιωαννης Αντωνιου Βεργουλλης Εξατομικευσιμοι στυλοι αποτυπωσης, ανοικτου τυπου ευθεις και κλειστου τυπου, ευθεις και κεκλιμενοι κι ανεξαρτητα εξαρτηματα υλοποιησης και επαληθευσης της διαδικασιας αποτυπωσης οδοντικων εμφυτευματων
FR3042121A1 (fr) 2015-10-08 2017-04-14 Jean-Marc Limacher Composition anti-tumorale
WO2025049941A1 (en) * 2023-08-31 2025-03-06 Arizona Board Of Regents On Behalf Of Arizona State University Attenuated vaccinia virus vaccines for monkeypox
FR3160186A1 (fr) 2024-03-13 2025-09-19 Odimma Therapeutics Vecteur non-viral pour transcription augmentee
FR3171450A1 (fr) 2025-01-17 2026-07-24 Odimma Therapeutics Virus enveloppé pour la transfection d’acides nucléiques exogènes.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230198B1 (hu) 2000-11-23 2015-10-28 Bavarian Nordic A/S Módosított Vacciniavírus Ankara-variáns
US7369860B2 (en) * 2002-01-08 2008-05-06 Siemens Aktiengesellschaft Data protection for position-dependent services
EP1420822B2 (en) 2002-04-19 2017-07-05 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
UA82479C2 (uk) 2002-05-16 2008-04-25 Бавариан Нордика А/С Міжгенні регіони як сайти вставки в геном модифікованого вірусу коров'ячої віспи ankara (mva)
JP5052893B2 (ja) * 2003-02-20 2012-10-17 アメリカ合衆国 ポックスベクターにおける新規の挿入部位
US6960345B2 (en) * 2003-03-06 2005-11-01 Incell Corporation, Llc Oral vaccinia formulation
WO2004087201A2 (en) 2003-03-28 2004-10-14 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mva virus expressing modified hiv envelope, gag, and pol genes
CN101128217B (zh) 2005-02-23 2012-04-25 巴法里安诺迪克有限公司 改良的痘病毒快速诱导抗痘病毒或其它传染物的免疫力的用途
WO2008076157A2 (en) * 2006-09-08 2008-06-26 Duke University Modified vaccinia ankara virus vaccine
US8268327B2 (en) * 2007-04-27 2012-09-18 Bavarian Nordic A/S Immediate protection against pathogens via MVA

Also Published As

Publication number Publication date
JP2016026180A (ja) 2016-02-12
CA2676809C (en) 2018-01-09
SI2152305T1 (sl) 2016-03-31
IL200073A (en) 2015-07-30
AU2008243344B2 (en) 2012-09-13
US8961998B2 (en) 2015-02-24
NZ578662A (en) 2012-08-31
DK2152305T3 (en) 2016-01-11
JP5702137B2 (ja) 2015-04-15
EP2152305A1 (en) 2010-02-17
JP5988463B2 (ja) 2016-09-07
US20110177114A1 (en) 2011-07-21
JP2010525000A (ja) 2010-07-22
CA2676809A1 (en) 2008-11-06
HUE025635T2 (en) 2016-04-28
MY162218A (en) 2017-05-31
CY1117301T1 (el) 2017-04-26
US20130216572A1 (en) 2013-08-22
US8268327B2 (en) 2012-09-18
IL200073A0 (en) 2010-04-15
ES2556175T3 (es) 2016-01-13
US20100129404A1 (en) 2010-05-27
JP2014015473A (ja) 2014-01-30
EP2152305B1 (en) 2015-09-23
US8268328B2 (en) 2012-09-18
WO2008131927A1 (en) 2008-11-06
AU2008243344A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
IL200073A0 (en) Immediate protection against pathogens via mva
AU317857S (en) Chest protector
ZA200906875B (en) Protective device
GB0921781D0 (en) Fraud protection
EP2161731A4 (en) PROTECTION ELEMENT
GB0816758D0 (en) Subsea protection device
EP2207438A4 (en) PROTECTIVE CLOTHING
ZA201009141B (en) Protective devices
IL180536A0 (en) Protective gaiter
PL2222577T3 (pl) Blok ochronny
SI2272146T1 (sl) Zaščitna naprava
GB0819084D0 (en) ESD protection
GB0714226D0 (en) anti-bacterial combination therapy
GB0822028D0 (en) Protective suit
GB0709705D0 (en) Protective clothing
GB0709354D0 (en) Knee protector
EP2194803A4 (en) PROTECTION SYSTEM
GB0715022D0 (en) Protector
GB0624751D0 (en) Improved protection device
GB0724464D0 (en) Protective clothing
GB0715782D0 (en) Rutguard protection
HU0700742D0 (en) Holograpmic quantum-copy protection
GB0721320D0 (en) Copyright protection
GB0722144D0 (en) Confidentaility protector
GB0700838D0 (en) Padlock protector